phive2015 JP Morgan raised its rating of Glaukos (NYSE:GKOS) to overweight, citing the company’s recently approved ophthalmology product iDose. The…
Read More »phive2015 JP Morgan raised its rating of Glaukos (NYSE:GKOS) to overweight, citing the company’s recently approved ophthalmology product iDose. The…
Read More »